Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

1F3J

HISTOCOMPATIBILITY ANTIGEN I-AG7

Summary for 1F3J
Entry DOI10.2210/pdb1f3j/pdb
DescriptorH-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, MHC CLASS II NOD, LYSOZYME C, ... (5 entities in total)
Functional Keywordshistocompatibility antigen, mhc, peptide complex, immune system
Biological sourceMus musculus (house mouse)
More
Total number of polymer chains6
Total formula weight90615.08
Authors
Latek, R.R.,Unanue, E.R.,Fremont, D.H. (deposition date: 2000-06-04, release date: 2000-09-20, Last modification date: 2024-10-30)
Primary citationLatek, R.R.,Suri, A.,Petzold, S.J.,Nelson, C.A.,Kanagawa, O.,Unanue, E.R.,Fremont, D.H.
Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice.
Immunity, 12:699-710, 2000
Cited by
PubMed Abstract: We have determined the crystal structure of I-Ag7, an integral component in murine type I diabetes development. Several features distinguish I-Ag7 from other non-autoimmune-associated MHC class II molecules, including novel peptide and heterodimer pairing interactions. The binding groove of I-Ag7 is unusual at both terminal ends, with a potentially solvent-exposed channel at the base of the P1 pocket and a widened entrance to the P9 pocket. Peptide binding studies with variants of the hen egg lysozyme I-Ag7 epitope HEL(11-25) support a comprehensive structure-based I-Ag7 binding motif. Residues critical for T cell recognition were investigated with a panel of HEL(11-25)-restricted clones, which uncovered P1 anchor-dependent structural variations. These results establish a framework for future experiments directed at understanding the role of I-Ag7 in autoimmunity.
PubMed: 10894169
DOI: 10.1016/S1074-7613(00)80220-4
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.1 Å)
Structure validation

226707

数据于2024-10-30公开中

PDB statisticsPDBj update infoContact PDBjnumon